Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MONTELUKAST SODIUM, with a corresponding US DMF Number 21702.
Remarkably, this DMF maintains an Active status since its submission on June 16, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 22, 2013, and payment made on December 03, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II